• CK2 Phosphorylation Tunes LOH2 and Plant Immunity

  2026-10-05

  Zhang et al. show that CK2 phosphorylation creates a regulatory trade-off in the Arabidopsis ceramide synthase LOH2: it increases catalytic activity and substrate affinity while also promoting polyubiquitination and proteasomal turnover. The work connects this post-translational control to C16 ceramide accumulation, salicylic acid signaling, cell death, and resistance to biotic stress, establishing a mechanistic framework for phosphorylation-dependent control of plant sphingolipid metabolism.

• TSPAN18–STIM1 Axis in Prostate Cancer Bone Metastasis

  2026-10-05

  Zhou et al. identify TSPAN18 as a regulator of STIM1 stability and show that protection from TRIM32-mediated ubiquitination strengthens calcium signaling associated with prostate cancer bone metastasis. The study provides a mechanistic link between protein turnover, store-operated calcium entry, metastatic behavior, and clinical disease associations, while leaving therapeutic translation to future validation.

• TUNEL Evidence in Neonatal Sevoflurane Neurotoxicity

  2026-10-04

  A source-grounded overview of how TUNEL-based DNA fragmentation detection was used in a neonatal mouse study of sevoflurane neurotoxicity, with attention to FITC-labeled dUTP incorporation, evidence strength, interpretation limits, and the boundaries of translating apoptosis findings to human health.

• HEV Organoids Reveal Pan-Tissue Infection

  2026-10-03

  A 2025 Gut study developed induced pluripotent stem cell-derived liver, intestinal, and brain organoids that supported propagation of HEV genotypes 1, 3, and 4. The models revealed cell-type-specific infection, organ injury phenotypes, and partial response to ribavirin, providing a physiologically richer platform for studying HEV pathogenesis and antiviral responses.

• Flavopiridol A3417: Reliable CDK Assays

  2026-10-01

  Flavopiridol (SKU A3417) offers a practical, mechanistically defined approach to studying CDK-dependent proliferation, cell-cycle arrest, and cytotoxicity. This scenario-based guide explains formulation, dose planning, interpretation, ER-stress comparisons, and vendor-selection criteria for more defensible cancer research workflows.

• Toremifene Workflows for Prostate Cancer Research

  2026-10-01

  Toremifene enables controlled interrogation of estrogen receptor biology alongside growth, migration, and calcium-signaling readouts. This workflow-focused guide shows how to connect SERM pharmacology with the TSPAN18–STIM1 metastasis model without overstating an unproven direct mechanism.

• Telmisartan in Cardiac Hypertrophy Assay Design

  2026-09-30

  Telmisartan is an angiotensin II receptor antagonist useful for separating AT1R-driven remodeling from downstream RIP3/CaMKII signaling in cardiac hypertrophy models. This article translates recent mechanistic findings into a decision framework for cardiovascular disease research, assay controls, and compound handling.

• Degarelix Acetate in Prostate Cancer Therapy

  2026-09-30

  The 2009 review by Laurence Klotz describes Degarelix acetate as a third-generation GnRH receptor antagonist that suppresses androgen signaling without the testosterone surge associated with GnRH agonists. Its clinical importance lies in rapid testosterone and prostate-specific antigen responses, a monthly subcutaneous formulation, and a safety profile considered comparable with established agonist therapy at the time of publication.

• Oral Dextran Microgels for Local Colon Cancer Therapy

  2026-09-29

  The reference study develops an orally administered, sequentially targeted system that combines dextran microgels with cisplatin/SPION lipid nanoparticles for localized colon cancer treatment. Its design links colon-specific enzymatic release, folate-receptor-mediated uptake, and magnetic hyperthermia to improve tumor control while limiting systemic exposure.

• Vitamin C Workflows for Cancer and HEV Organoids

  2026-09-29

  Build reproducible ascorbic acid dose–response workflows for tumor-cell assays while using multilineage organoids to test tissue-specific injury and host responses. The approach separates established anticancer evidence from exploratory HEV applications, helping researchers avoid mistaking general cytotoxicity for antiviral activity.

• AR and ARv7 in TNBC: EPI-001 Study Insights

  2026-09-28

  This 2025 study links androgen receptor (AR) and AR splice variant 7 (ARv7) expression with unfavorable outcomes and metastatic risk in triple-negative breast cancer (TNBC). In MDA-MB-231 cells, pharmacologic targeting with enzalutamide or the androgen receptor N-terminal domain inhibitor EPI-001 altered migration- and epithelial-to-mesenchymal transition-associated markers, supporting ARv7-focused investigation in TNBC.

• PX-478 2HCl in Hypoxia Signaling Research

  2026-09-28

  PX-478 2HCl offers a practical way to perturb HIF-1α in cell-based hypoxia studies and selected in vivo models. A prenatal-hypoxia rat study extends its research use into neurodevelopmental assays, while also highlighting why timing, safety readouts, and model-specific validation matter.

• 4μ8C Workflows for ER Stress Research

  2026-09-27

  Use 4μ8C to separate IRE1α RNase-dependent stress signaling from cell-growth outcomes in hypoxia and cancer cell models. This guide pairs practical dose-finding and pathway readouts with clear limits: the compound is a preclinical in vitro tool, not an established in vivo treatment.

• Alfuzosin HCl: From Receptor Biology to Assay Design

  2026-09-26

  Explore how Alfuzosin HCl connects α1-adrenoceptor pharmacology with practical assay design for benign prostatic hyperplasia research. A micellar spectrofluorimetric study illustrates when fluorescence can support measurements in tablets and biological samples—and where matrix-specific validation remains essential.

• Cy5 Detection in Exosomal Wnt10a Osteogenesis

  2026-09-25

  A translational perspective on validating lithium–exosome osteogenesis mechanisms with fluorescence assays, and on selecting a Cy5 secondary antibody for mouse-primary detection.

8565 records 1/571 page Next 12345 下5页 Last page